Institutional investors purchased a net $1.3 million shares of OMER during the quarter ended March 2016, and now own 56.82% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
PRINCIPAL MANAGEMENT CORP. Bought 25.5 Thousand shares of Omeros Corp